These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1448839)

  • 1. Prediction of unbound serum valproic acid concentration by using in vivo binding parameters.
    Kodama Y; Kuranari M; Tsutsumi K; Kimoto H; Fujii I; Takeyama M
    Ther Drug Monit; 1992 Oct; 14(5):349-53. PubMed ID: 1448839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of binding equation method for prediction of unbound serum valproic acid concentration in pediatric patients with epilepsy.
    Kodama Y; Kuranari M; Kodama H; Koike Y; Yasunaga F; Fujii I; Takeyama M
    Int J Clin Pharmacol Ther; 1995 Feb; 33(2):114-8. PubMed ID: 7757310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Binding Equation Method for Unbound Serum Concentration Prediction of Valproic Acid in Polytherapy Pediatric Patients with Epilepsy.
    Kodama Y; Kuranari M; Kodama H; Ashikari Y; Fujii I; Takeyama M
    Am J Ther; 1995 Feb; 2(2):106-111. PubMed ID: 11847536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of equations for predicting bound serum concentrations of carbamazepine and carbamazepine-10, 11-epoxide after polytherapy in patients with epilepsy.
    Kodama Y; Kuranari M; Kodama H; Tsutsumi K; Fujii I; Takeyama M
    J Clin Pharmacol; 1995 Oct; 35(10):995-1002. PubMed ID: 8568018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of unbound serum carbamazepine and carbamazepine-10,11-epoxide concentration prediction methods in polytherapy adult patients with epilepsy.
    Kodama Y; Kuranari M; Fujii I; Kodama H; Takeyama M
    Am J Ther; 1996 Oct; 3(10):699-707. PubMed ID: 11862225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of two binding equations for prediction of the concentration of unbound valproic acid in the serum of adult epileptic polytherapy patients.
    Kodama Y; Kuranari M; Kodama H; Zaizen T; Yukawa E; Fujii I; Takeyama M
    J Pharm Pharmacol; 1996 Oct; 48(10):1068-72. PubMed ID: 8953510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting unbound phenytoin concentrations in patients receiving valproic acid: a comparison of two prediction methods.
    Kerrick JM; Wolff DL; Graves NM
    Ann Pharmacother; 1995 May; 29(5):470-4. PubMed ID: 7655129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding parameters of valproic acid to serum protein in healthy adults at steady state.
    Kodama Y; Koike Y; Kimoto H; Yasunaga F; Takeyama M; Teraoka I; Fujii I
    Ther Drug Monit; 1992 Feb; 14(1):55-60. PubMed ID: 1546390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of equations for unbound serum concentration prediction of carbamazepine and carbamazepine-10,11-epoxide in polytherapy pediatric patients with epilepsy.
    Kodama Y; Kuranari M; Kodama H; Fujii I; Takeyama M
    J Pharm Sci; 1995 Jul; 84(7):835-9. PubMed ID: 7562433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical implications of serum protein binding in epileptic children during sodium valproate maintenance therapy.
    Yu HY
    Ther Drug Monit; 1984; 6(4):414-23. PubMed ID: 6440321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender- or age-related binding characteristics of valproic acid to serum proteins in adult patients with epilepsy.
    Kodama Y; Kodama H; Kuranari M; Tsutsumi K; Ono S; Yukawa E; Fujimura A
    Eur J Pharm Biopharm; 2001 Jul; 52(1):57-63. PubMed ID: 11438424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can the serum protein binding of valproic acid limit the hepatic elimination?
    Kodama Y; Kuranari M; Teraoka I; Fujii I; Takeyama M
    Int J Clin Pharmacol Ther Toxicol; 1993 Nov; 31(11):529-32. PubMed ID: 8294164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No effect of gender or age on binding characteristics of valproic acid to serum proteins in pediatric patients with epilepsy.
    Kodama Y; Kodama H; Kuranari M; Tsutsumi K; Ono S; Fujimura A
    J Clin Pharmacol; 1999 Oct; 39(10):1070-6. PubMed ID: 10516942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring Protein-Unbound Valproic Acid Serum Concentrations in Clinical Practice.
    Wallenburg E; Klok B; de Jong K; de Maat M; van Erp N; Stalpers-Konijnenburg S; Essink G; van Luin M
    Ther Drug Monit; 2017 Jun; 39(3):269-272. PubMed ID: 28437285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein binding of valproic acid in Japanese pediatric and adult patients with epilepsy.
    Kodama Y; Kodama H; Kuranari M; Tsutsumi K; Ono S; Yamaguchi T; Fujimura A
    Am J Health Syst Pharm; 2002 May; 59(9):835-40. PubMed ID: 12004461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma protein binding of valproic acid in healthy subjects and in patients with renal disease.
    Gugler R; Mueller G
    Br J Clin Pharmacol; 1978 May; 5(5):441-6. PubMed ID: 350249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of total and free valproic acid during monotherapy in infants.
    Herngren L; Lundberg B; Nergårdh A
    J Neurol; 1991 Sep; 238(6):315-9. PubMed ID: 1940980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic parameters of total and unbound valproic acid and their relationships to seizure control in epileptic children.
    Panomvana Na Ayudhya D; Suwanmanee J; Visudtibhan A
    Am J Ther; 2006; 13(3):211-7. PubMed ID: 16772762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unbound valproate fraction in plasma and subcutaneous microdialysate in steady state and after a single dose in humans.
    Lindberger M; Tomson T; Ståhle L
    Ther Drug Monit; 2003 Jun; 25(3):378-83. PubMed ID: 12766568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of unbound clearance on binding parameters of valproic acid to serum proteins.
    Kodama Y; Tsutsumi K; Teraoka I; Fujii I; Takeyama M
    J Clin Pharmacol; 1993 Feb; 33(2):130-5. PubMed ID: 8440760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.